Mumbai: No urgent relief for Serum Institute in defamation suit

Mumbai: No urgent relief for Serum Institute in defamation suit

In a setback for the Serum Institute of India (SII), the Bombay High Court (HC) on Wednesday refused to grant it immediate relief in its defamation suit seeking damages to the tune of Rs100 crore from organisations and individuals who were allegedly posting erroneous content against the company and its CEO Adar Poonawalla.

Staff ReporterUpdated: Friday, December 23, 2022, 04:17 AM IST
article-image
Adar Poonawalla | File Photo

Mumbai: In a setback for the Serum Institute of India (SII), the Bombay High Court (HC) on Wednesday refused to grant it immediate relief in its defamation suit seeking damages to the tune of Rs100 crore from organisations and individuals who were allegedly posting erroneous content against the company and its CEO Adar Poonawalla.

Justice NJ Jamadar said that the matter was bulky and it would not be possible to hear the parties in a day to grant urgent relief. The HC has kept the matter for hearing on Jan 3, 2023. The court, however, granted SII the liberty to approach the vacation bench in case of urgent relief.

SII's suit is against the defendants – Yohan Tengra and his organisation Anarchy for Freedom India, and Ambar Koiri and his organisation Awaken India Movement – who have been posting and circulating defamatory content against SII.

The suit emphasised that the defendants had also been posting incorrect information about the legal proceedings wherein SII was involved. It further elaborated that the defendants have been posting content alleging that the Covishield – the anti-Covid vaccine produced by the institute – caused the deaths of multiple persons due to side effects.

Apart from Rs100 crore as damages, the SII has sought an unconditional apology from the defendants. The suit has also sought an injunction against social media platforms such as YouTube and Twitter to take down the defamatory content and to ensure that no such content is published against SII in the future.

As an interim relief, the suit prayed that the defendants be temporarily restrained from publishing, circulating any content against SII or its employees. The defendants, through their advocates Nilesh Ojha and Tanveer Nizam, filed a reply seeking dismissal of the suit. They also sought prosecution of SII for making incorrect statements about the effects of the Covishield vaccine. The HC has asked SII to file its additional affidavit in response to the defendants' reply.

RECENT STORIES

Mumbai: Kandivali Man Upset Over Not Being Served Dosas First Abuses Woman, Minor Daughter; Booked...

Mumbai: Kandivali Man Upset Over Not Being Served Dosas First Abuses Woman, Minor Daughter; Booked...

Ghatkopar Hoarding Collapse: Death Toll Rises To 17 In Billboard Mishap After Injured Man Dies At...

Ghatkopar Hoarding Collapse: Death Toll Rises To 17 In Billboard Mishap After Injured Man Dies At...

Mumbai HSC 12th Result 2024: St Xavier's Jr College Science Student Excels With 97%

Mumbai HSC 12th Result 2024: St Xavier's Jr College Science Student Excels With 97%

Mumbai: Visually Impaired Girl Tops Her School In HSC 2024

Mumbai: Visually Impaired Girl Tops Her School In HSC 2024

Mumbai HSC 12th Result 2024 “Had To Quit Social Media”, 95.5% Scorer In HSC Arts

Mumbai HSC 12th Result 2024 “Had To Quit Social Media”, 95.5% Scorer In HSC Arts